Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: A randomized clinical trial

British Journal of Anaesthesia

Volumn 96, Issue 5, 2006, Pages 576-582

  Camarasa, M A ^a,c   Olle G ^a   Serra Prat, M ^b   Martin A ^a   Sanchez M ^a   Ricos P ^a   Perez A ^a   Opisso, L ^a  

^a HOSPITAL DE MATARÓ   (Spain)

^b Unidad de Investigacion   (Spain)

^c NONE   (Spain)

Author keywords

Agents, antifibrinolytic, 6 aminocaproic acid; Agents, antifibrinolytic, tranexamic acid; Blood, loss, surgical; Surgery, arthroplasty, knee replacement

Indexed keywords

AMINOCAPROIC ACID; HEMOGLOBIN; PLACEBO; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLEEDING; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARALLEL DESIGN; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; TOTAL KNEE REPLACEMENT; TOURNIQUET;

EID: 33645892258     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/ael057     Document Type: Article

References (26)

1. Jansen AJ, Andreica S, Claeys M, D'Haese J, Camu F, Jochmans K. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 1999; 83: 596-601
2. Fahmy NR, Patel DG. Hemostatic changes and postoperative deep-vein thrombosis associated with use of a pneumatic tourniquet. J Bone Joint Surg Am 1981; 63-A: 461-5
3. Risberg B. The response of the fibrinolytic system in trauma. Acta Chir Scand 1985; Suppl 522: 245-71
4. Spahn DR, Cassut M. Eliminating blood transfusions. New aspects and perspectives. Anesthesiology 2000; 93: 242-55
5. Ho K, Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: A meta-analysis. Anaesth Intensive Care 2003; 31: 529-37
6. Zohar E, Ellis M, Ifrach N, Stern A, Sapir O, Fredman B. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anaesth Analg 2004; 99: 1679-83
7. Yamasaki S, Masuhara K, Fuji T. Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty. J Bone Joint Surg Am 2005; 87: 766-70
8. Bennett-Gerrero E, Sorohan J, Gurevich M, et al. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations. Anesthesiology 1997; 87: 1373-80
9. Munoz J, Birkmeyer N, Birkmeyer J, O'Connor G, Dacey L. Is aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery. Circulation 1999; 99: 81-9
10. Hardy J, Belisle S, Dupont C, Harel F, Robitaille D, Roy M, Gagnon L. Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization. ATS 1998; 65: 371-6
11. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss, blood transfusion after knee arthroplasty. J Bone Joint Surg Br 1996; 78-B: 434-40
12. Horrow J, Van Riper D, Strong M, Grunewald K, Parmet J. The dose-response relationship of tranexamic acid. Anesthesiology 1995; 82: 383-92
13. Hedlung PO. Antifibrinolytic therapy with Cyklokapron in connection with prostatectomy: A double blind study. Scand J Urol Nephrol 1969; 3: 177-82
14. Dunn CJ, Goa KL. Tranexamic acid. A review of its use in surgery and other indications. Drugs 1999; 57: 1005-32
15. Boylan JF, Klinck JR, Sandler AN, et al. Tranexamic acid reduces blood loss, transfusions requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 1996; 85: 1043-8
16. Dalmau A, Sabate A, Acosta F, et al. Tranexamic acid reduces red cell transfusion better than epsilon-amino-caproic acid or placebo in liver transplantation. Anesth Analg 2000; 91: 29-34
17. Toshiya S, Zen'ichiro W, Tetsuo I, Atsuhiro S. Aprotinin in major orthopedic surgery: A systematic review of randomized controlled trials. Anesth Analg 2005; 101: 1602-7
18. Mahdy A, Webster N. Perioperative systemic haemostatic agents. Br J Anaesth 2004; 93: 842-58
19. Harley B, Beaupré L, Jones A, Cinats J, Guenther C. The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: A pilot study. Can J Surg 2002; 45: 185-90
20. Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 2003; 90: 596-9
21. Hiippala ST, Strid LJ, Wennerstrand MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 1997; 84: 839-44
22. Cid J, Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: Results of a meta-analysis of randomized controlled trials. Transfusion 2005; 45: 1302-7
23. Conseiller C, Ozier Y, Rosencher N. Compensación de las pérdidas de glóbulos rojos en cirugía. Encid Méd Quir2000-E-36-735-B-10
24. Benoni G, Björkman S, Fredin H. Application of pharmacokinetic data from healthy volunteers for the prediction of plasma concentrations of tranexamic acid in surgical patients. Clin Drug Invest 1995; 10: 280-7
25. Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 2001; 83: 702-5
26. Kinzel V, Shakespeare D, Derbyshire D. The effect of aprotinin on blood loss in bilateral total knee arthroplasty. Knee 2004; 12: 107-11